AdvanSix (NYSE:ASIX – Get Free Report) and ASP Isotopes (NASDAQ:ASPI – Get Free Report) are both small-cap materials companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, risk, institutional ownership, profitability, earnings, dividends and valuation.
Analyst Ratings
This is a breakdown of recent recommendations for AdvanSix and ASP Isotopes, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| AdvanSix | 1 | 2 | 0 | 0 | 1.67 |
| ASP Isotopes | 1 | 0 | 2 | 0 | 2.33 |
AdvanSix presently has a consensus target price of $22.50, suggesting a potential upside of 12.21%. ASP Isotopes has a consensus target price of $13.00, suggesting a potential upside of 217.07%. Given ASP Isotopes’ stronger consensus rating and higher probable upside, analysts plainly believe ASP Isotopes is more favorable than AdvanSix.
Institutional and Insider Ownership
Volatility & Risk
AdvanSix has a beta of 1.29, suggesting that its share price is 29% more volatile than the S&P 500. Comparatively, ASP Isotopes has a beta of 3.61, suggesting that its share price is 261% more volatile than the S&P 500.
Valuation & Earnings
This table compares AdvanSix and ASP Isotopes”s gross revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| AdvanSix | $1.52 billion | 0.36 | $49.29 million | $0.37 | 54.19 |
| ASP Isotopes | $26.93 million | 23.34 | -$175.09 million | ($2.08) | -1.97 |
AdvanSix has higher revenue and earnings than ASP Isotopes. ASP Isotopes is trading at a lower price-to-earnings ratio than AdvanSix, indicating that it is currently the more affordable of the two stocks.
Profitability
This table compares AdvanSix and ASP Isotopes’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| AdvanSix | 0.67% | 2.18% | 1.05% |
| ASP Isotopes | -644.40% | -112.46% | -53.36% |
Summary
AdvanSix beats ASP Isotopes on 8 of the 14 factors compared between the two stocks.
About AdvanSix
AdvanSix Inc. engages in the manufacture and sale of polymer resins in the United States and internationally. It offers Nylon 6, a polymer resin, which is a synthetic material used to produce fibers, filaments, engineered plastics, and films. The company also provides caprolactam to manufacture polymer resins; ammonium sulfate fertilizers to distributors, farm cooperatives, and retailers; and acetone that are used in the production of adhesives, paints, coatings, solvents, herbicides, and engineered plastic resins, as well as other intermediate chemicals, including phenol, monoisopropylamine, dipropylamine, monoallylamine, alpha-methylstyrene, cyclohexanone, methyl ethyl ketoxime, acetaldehyde oxime, 2-pentanone oxime, cyclohexanol, sulfuric acid, ammonia, and carbon dioxide. It offers its products under the Aegis, Capran, Sulf-N, Nadone, Naxol, and EZ-Blox brands. The company sells its products directly, as well as through distributors. AdvanSix Inc. was incorporated in 2016 and is headquartered in Parsippany, New Jersey.
About ASP Isotopes
ASP Isotopes Inc., a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235. ASP Isotopes Inc. was incorporated in 2021 and is headquartered in Washington, District Of Columbia.
Receive News & Ratings for AdvanSix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AdvanSix and related companies with MarketBeat.com's FREE daily email newsletter.
